Pictet North America Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Pictet North America Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,282	Closed	-$1.02M	–	129
2021 Q3	$1.02M	Hold	17,282	–	–	0.1%	75
2021 Q2	$1.16M	Hold	17,282	–	–	0.12%	73
2021 Q1	$1.09M	Hold	17,282	–	–	0.13%	71
2020 Q4	$1.07M	Sell	17,282 -502	-3%	-$30.9K	0.14%	75
2020 Q3	$1.07M	Sell	17,784 -1	-0%	-$60	0.15%	75
2020 Q2	$1.05M	Buy	17,785 +400	+2%	+$23.9K	0.15%	75
2020 Q1	$969K	Sell	17,385 -1,000	-5%	-$61.1K	0.17%	78
2019 Q4	$1.18M	Buy	+18,385	New	+$1.05M	0.15%	79

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pictet North America Advisors's BMY Position: Q4 2021 in Review

Pictet North America Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 17,282 shares — an estimated $1.02M sold.

Pictet North America Advisors first reported a position in BMY in Q4 2019 and held it in 8 quarters. The position peaked at $1.18M in Q4 2019. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Pictet North America Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Pictet North America Advisors sold 17,282 Bristol-Myers Squibb shares in Q4 2021, an estimated $1.02M.
Pictet North America Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 8 quarters.
Pictet North America Advisors's Bristol-Myers Squibb position peaked at $1.18M in Q4 2019.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Pictet North America Advisors's 13F filing for Q4 2021, filed 4 Feb 2022.